Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 3/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24328853 | 1.00 | IMPDH2 (0.32) | IMPDH2AAK1CYP4F2CYP4A11 | |
| SCHEMBL27515499 | 0.75 | PTGS2 (0.34) | AAK1 | |
| SCHEMBL24327756 | 0.71 | KMT2A (0.35) | — | |
| SCHEMBL26940504 | 0.71 | KMT2A (0.35) | — | |
| SCHEMBL26940434 | 0.68 | KMT2A (0.55) | — | |
| SCHEMBL26940463 | 0.68 | KMT2A (0.55) | — | |
| SCHEMBL11797169 | 0.68 | KMT2A (0.55) | — | |
| SCHEMBL24327736 | 0.66 | CTSA (0.40) | — | |
| SCHEMBL24327733 | 0.66 | CYP3A4 (0.33) | — | |
| SCHEMBL24328902 | 0.66 | CPB2 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| WO-2022078416-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | GLUL, GATD3, GLS | IMPDH2 2728/4885AAK1 3523/4885CYP4F2 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.